D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$700M |
| 2 |
Qualcomm
QCOM
|
+$525M |
| 3 |
Marathon Petroleum
MPC
|
+$522M |
| 4 |
Walmart Inc
WMT
|
+$503M |
| 5 |
Ford
F
|
+$474M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$672M |
| 2 |
Merck
MRK
|
+$476M |
| 3 |
Meta Platforms (Facebook)
META
|
+$392M |
| 4 |
McDonald's
MCD
|
+$372M |
| 5 |
Wells Fargo
WFC
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.62% |
| 2 | Consumer Discretionary | 9.84% |
| 3 | Healthcare | 7.45% |
| 4 | Communication Services | 7.19% |
| 5 | Financials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Willis Towers Watson
WTW
$27.9B
| $291K | ﹤0.01% |
1,264
+315
| +33% | +$78.3K |
|
4127
PUT
Coherent
COHR
$55.2B
| $290K | ﹤0.01% |
+4,000
| New | +$282K |
|
4128
PUT
PVH
PVH
$3.71B
| $290K | ﹤0.01% |
2,700
-10,000
| -79% | -$1.1M |
|
|
PRPB.WS
4129
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
| $289K | ﹤0.01% |
212,500
| – | – |
|
4130
John B. Sanfilippo & Son
JBSS
$949M
| $288K | ﹤0.01% |
3,253
-3,737
| -53% | -$340K |
|
4131
The Joint Corp
JYNT
$119M
| $288K | ﹤0.01% |
3,433
-52,217
| -94% | -$3.24M |
|
4132
LENSAR
LNSR
$68.8M
| $288K | ﹤0.01% |
33,306
-6,589
| -17% | -$51K |
|
4133
Nicolet Bankshares
NIC
$3.57B
| $288K | ﹤0.01% |
4,088
-3,405
| -45% | -$266K |
|
|
DLCAU
4134
DELISTED
Deep Lake Capital Acquisition Corp. Unit
DLCAU
| $288K | ﹤0.01% |
28,467
+11,767
| +70% | +$119K |
|
4135
Pulse Biosciences
PLSE
$2.09B
| $287K | ﹤0.01% |
+17,528
| New | +$334K |
|
4136
Smart Sand
SND
$200M
| $287K | ﹤0.01% |
+86,169
| New | +$225K |
|
4137
Albemarle
ALB
$13.5B
| $286K | ﹤0.01% |
1,696
-49,111
| -97% | -$7.93M |
|
4138
CALL
Cameco
CCJ
$38.3B
| $286K | ﹤0.01% |
+14,900
| New | +$281K |
|
4139
Idexx Laboratories
IDXX
$42.9B
| $285K | ﹤0.01% |
452
-636
| -58% | -$351K |
|
4140
PUT
Banco Bradesco
BBD
$38.1B
| $282K | ﹤0.01% |
60,500
-484,000
| -89% | -$2.1M |
|
4141
LeMaitre Vascular
LMAT
$2.18B
| $282K | ﹤0.01% |
4,619
-14,012
| -75% | -$744K |
|
4142
HUTCHMED
HCM
$1.89B
| $281K | ﹤0.01% |
7,162
-19,408
| -73% | -$560K |
|
4143
PUT
Sturm, Ruger & Co
RGR
$610M
| $279K | ﹤0.01% |
+3,100
| New | +$232K |
|
4144
PUT
Texas Capital Bancshares
TCBI
$4.31B
| $279K | ﹤0.01% |
4,400
+300
| +7% | +$20.2K |
|
4145
Liberty Latin America Class A
LILA
$1.51B
| $278K | ﹤0.01% |
+29,493
| New | +$280K |
|
|
NOAH
4146
Noah Holdings
NOAH
$588M
| $278K | ﹤0.01% |
+5,899
| New | +$261K |
|
|
NBSE
4147
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $278K | ﹤0.01% |
2,899
-1,913
| -40% | -$211K |
|
|
AKYA
4148
DELISTED
Akoya BioSciences
AKYA
| $277K | ﹤0.01% |
+14,309
| New | +$295K |
|
|
CGAU
4149
Centerra Gold
CGAU
$3.22B
| $276K | ﹤0.01% |
+36,300
| New | +$302K |
|
4150
GT Biopharma
GTBP
$11.7M
| $275K | ﹤0.01% |
+591
| New | +$246K |
|
Similar funds
D.E. Shaw & Co's Q2 2021 Portfolio in Review
As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
- D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
- D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
- D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
- D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.